摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-[4-(4-benzo[b]thiophen-4-ylpiperazin-1-yl)butoxy]-1H-quinolin-2-one phosphate | 1427049-30-6

中文名称
——
中文别名
——
英文名称
7-[4-(4-benzo[b]thiophen-4-ylpiperazin-1-yl)butoxy]-1H-quinolin-2-one phosphate
英文别名
7-[4-(4-benzo[b]thiophene -4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one phosphate;7-[4-(4-Benzo[b]thiophen-4-yl-piperazin-1-yl)-butoxy]-1H-quinolin-2-one phosphate;7-[4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one;phosphoric acid
7-[4-(4-benzo[b]thiophen-4-ylpiperazin-1-yl)butoxy]-1H-quinolin-2-one phosphate化学式
CAS
1427049-30-6
化学式
C25H27N3O2S*H3O4P
mdl
——
分子量
531.569
InChiKey
YHPMOSJNBZAWIY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    36
  • 可旋转键数:
    7
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    151
  • 氢给体数:
    4
  • 氢受体数:
    9

反应信息

  • 作为产物:
    描述:
    依匹唑派溶剂黄146磷酸 作用下, 以 乙醇 为溶剂, 以41.96 g的产率得到7-[4-(4-benzo[b]thiophen-4-ylpiperazin-1-yl)butoxy]-1H-quinolin-2-one phosphate
    参考文献:
    名称:
    ORAL PHARMACEUTICAL COMPOSITION
    摘要:
    提供了一种能够防止活性成分初期过量释放的手段,并且能够在较长时间内实现活性成分的药效活性剂量的持续释放。
    公开号:
    EP4015001A1
点击查看最新优质反应信息

文献信息

  • [EN] PIPERAZINE- SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS<br/>[FR] DÉRIVÉS DE BENZOTHIOPHÈNE SUBSTITUÉ PAR PIPÉRAZINE EN TANT QU'AGENTS ANTIPSYCHOTIQUES
    申请人:OTSUKA PHARMA CO LTD
    公开号:WO2013035892A1
    公开(公告)日:2013-03-14
    Provided is a superior, novel heterocyclic compound with improved solubility in oil such as sesame oil and benzyl benzoate, which has a broader treatment spectrum, causes less side effects, and is superior in tolerability and safety, and use thereof. A heterocyclic compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof.
    提供了一种优越的、新颖的杂环化合物,其在油中的溶解性得到改善,如芝麻油和苯基苯甲酸酯,具有更广泛的治疗范围,引起的副作用更少,在耐受性和安全性方面更为优越,以及其使用。表示为式(I)的杂环化合物,其中每个符号如规范中定义的,或其盐。
  • 医薬
    申请人:大塚製薬株式会社
    公开号:JP2018203793A
    公开(公告)日:2018-12-27
    To provide a novel medicine that has a wide therapeutic spectrum, reduced side effects, excellent tolerability and safety, and improved solubility in oil such as sesame oil and benzyl benzoate.SOLUTION: A medicine contains a heterocyclic compound represented by formula (I) [where each symbol is defined as in the specifications] or a salt thereof.SELECTED DRAWING: None
    提供一种具有广泛治疗范围、减少副作用、良好耐受性和安全性、以及在油中(如芝麻油和苯甲酸苄酯)溶解性改善的新型药物。解决方案:一种药物包含由式(I)表示的杂环化合物[其中每个符号的定义如规范中所述]或其盐。所选图纸:无
  • PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS
    申请人:Yamashita Hiroshi
    公开号:US20150045356A1
    公开(公告)日:2015-02-12
    Provided is a superior, novel heterocyclic compound with improved solubility in oil such as sesame oil and benzyl benzoate, which has a broader treatment spectrum, causes less side effects, and is superior in tolerability and safety, and use thereof. A heterocyclic compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof.
    提供了一种卓越的新型杂环化合物,其在油中(如芝麻油和苯甲酸苄酯)的溶解性得到改善,具有更广泛的治疗范围,引起较少的副作用,并且在耐受性和安全性方面更为卓越,其使用。该杂环化合物由式(I)表示,其中每个符号如规范中所定义,或其盐。
  • Piperazine-substituted benzothiophene derivatives as antipsychotic agents
    申请人:Yamashita Hiroshi
    公开号:US09260420B2
    公开(公告)日:2016-02-16
    Provided is a superior, novel heterocyclic compound with improved solubility in oil such as sesame oil and benzyl benzoate, which has a broader treatment spectrum, causes less side effects, and is superior in tolerability and safety, and use thereof. A heterocyclic compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof.
    提供了一种优良的新型杂环化合物,具有更好的油溶性,例如芝麻油和苯甲酸苄酯,具有更广泛的治疗范围,副作用更少,耐受性和安全性更好,并且可以使用。该杂环化合物由式(I)表示,其中每个符号如规范中所定义,或其盐。
  • US9260420B2
    申请人:——
    公开号:US9260420B2
    公开(公告)日:2016-02-16
查看更多